Kura Oncology Receivables

Kura Oncology (KURA) currently reports a receivables of $14M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Kura Oncology's receivables history and peer comparisons.

Kura Oncology's receivables changed from $0 to $14M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kura Oncology reported $14M in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kura Oncology, and consider following KURA for alerts when major investors trade the stock.

Kura Oncology is classified in the Healthcare sector. On receivables, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KURA with unrelated industries.